Arch Venture Corp
Latest statistics and disclosures from ARCH Venture Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are BEAM, RAPP, ERAS, VERV, GOSS, and represent 97.78% of ARCH Venture Management's stock portfolio.
- Added to shares of these 1 stock: CERO.
- Reduced shares in these 1 stock: BEAM (-$7.3M).
- ARCH Venture Management was a net seller of stock by $-6.8M.
- ARCH Venture Management has $230M in assets under management (AUM), dropping by -11.65%.
- Central Index Key (CIK): 0001274403
Tip: Access up to 7 years of quarterly data
Positions held by Arch Venture Corp consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for ARCH Venture Management
ARCH Venture Management holds 9 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Beam Therapeutics (BEAM) | 48.9 | $113M | -6% | 4.5M | 24.80 |
|
| Rapport Therapeutics (RAPP) | 28.7 | $66M | 3.7M | 17.74 |
|
|
| Erasca (ERAS) | 12.1 | $28M | 11M | 2.51 |
|
|
| Verve Therapeutics (VERV) | 4.9 | $11M | 2.0M | 5.64 |
|
|
| Gossamer Bio (GOSS) | 3.2 | $7.3M | 8.1M | 0.90 |
|
|
| Singular Genomics Systems Com New (OMIC) | 1.1 | $2.5M | 127k | 19.43 |
|
|
| Q32 Bio (QTTB) | 0.5 | $1.1M | 321k | 3.44 |
|
|
| Unity Biotechnology Com New (UBX) | 0.4 | $981k | 1.0M | 0.98 |
|
|
| Cero Therapeutics Holdings Class A Com (CERO) | 0.2 | $564k | +550% | 9.4M | 0.06 |
|
Past Filings by ARCH Venture Management
SEC 13F filings are viewable for ARCH Venture Management going back to 2018
- ARCH Venture Management 2024 Q4 filed Feb. 14, 2025
- ARCH Venture Management 2024 Q3 filed Nov. 14, 2024
- ARCH Venture Management 2024 Q2 filed Aug. 14, 2024
- ARCH Venture Management 2024 Q1 filed May 15, 2024
- ARCH Venture Management 2023 Q4 filed Feb. 14, 2024
- ARCH Venture Management 2023 Q3 filed Nov. 14, 2023
- ARCH Venture Management 2023 Q2 filed Aug. 9, 2023
- ARCH Venture Management 2023 Q1 filed May 15, 2023
- ARCH Venture Management 2022 Q4 filed Feb. 14, 2023
- ARCH Venture Management 2022 Q3 filed Nov. 10, 2022
- ARCH Venture Management 2022 Q2 filed Aug. 15, 2022
- ARCH Venture Management 2022 Q1 restated filed May 27, 2022
- ARCH Venture Management 2022 Q1 filed May 13, 2022
- ARCH Venture Management 2021 Q4 filed Feb. 14, 2022
- Arch Venture Corp 2020 Q3 filed Nov. 16, 2020
- Arch Venture Corp 2020 Q2 filed Aug. 12, 2020